Tiefenbacher Group at DCAT 2023 – Thanks for meeting us in New York City!

It has been four very successful and inspiring days for TIEFENBACHER GROUP in New York City. We were delighted to be able to participate in such an important event and look forward to expand these exciting meetings and interesting conversations that we had in the last days. We are happy to had the chance of presenting our latest ideas on how to make pharmaceuticals more affordable, more available, and better than before!

DCAT Week– one of the world´s most important pharma events – has just come to an end. It is the premier global event held annually in New York City for companies engaged in the Bio/Pharmaceutical Manufacturing Value Chain. It is hosted by the DCAT (Drug, Chemical & Associated Technologies Association), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

Check out our short video to get some impressions!

About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines  around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our goal is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.  

For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email atinfo@tiefenbacher.com or please visit us on: www.tiefenbacher-pharmaceuticals.com